Acute adverse reactions attributed to allopurinol in hospitalised patients.
Open Access
- 1 June 1981
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 40 (3) , 245-249
- https://doi.org/10.1136/ard.40.3.245
Abstract
Of 29 524 hospitalised medical patients monitored in a drug surveillance programme 1835 (6.2%) received the xanthine oxidase inhibitor allopurinol. After the exclusion of skin reactions adverse effects were attributed to this drug in 33 (1.8%) patients, the most frequent being haematological abnormalities (11 patients, 0.6%) and diarrhoea and drug fever (5 each, 0.3%). Adverse effects were dose-related. Reactions were unrelated to age, weight, reason for therapy, admission blood urea, or albumin concentrations. Acute exacerbation of gout was troublesome in 3 patients (1 in 600 exposed).Keywords
This publication has 30 references indexed in Scilit:
- Allopurinol hypersensitivity.BMJ, 1979
- Liver granulomas and allopurinol.BMJ, 1978
- Severe allopurinol hypersensitivity. Association with thiazides and prior renal compromiseArchives of internal medicine (1960), 1974
- Influence of allopurinol on drug metabolism in manBritish Journal of Pharmacology, 1973
- Severe Hypersensitivity Reactions Associated With AllopurinolPublished by American Medical Association (AMA) ,1971
- Toxic Epidermal Necrolysis, Azotemia, and Death After Allopurinol TherapyPublished by American Medical Association (AMA) ,1970
- Vasculitis with allopurinol therapyAmerican Heart Journal, 1970
- Renal clearance of oxipurinol, the chief metabolite of allopurinolThe American Journal of Medicine, 1968
- Metabolic studies of allopurinol, an inhibitor of xanthine oxidaseBiochemical Pharmacology, 1966
- Effect of allopurinol (4-Hydroxypyrazolo-(3,4-d)pyrimidine) on serum and urinary uric acid in primary and secondary goutThe American Journal of Medicine, 1964